During the past decade, Kitasato University Medical Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kitasato University Medical Center" #1 sponsor was "Bayer" with 2 trials, followed by "Boston Scientific Japan K.K." with 1 trials sponsored, "Horizon Therapeutics Ireland DAC" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Kitasato University Medical Center" are "Anemia" (2 trials), "Renal Insufficiency, Chronic" (2 trials), "Diffuse Cutaneous Systemic Sclerosis" (1 trials), "Neuralgia" (1 trials) and "Pain" (1 trials). Many other conditions were trialed in "Kitasato University Medical Center" in a lesser frequency.

Most popular intervention types in "Kitasato University Medical Center" are "Drug" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Darbepoetin alfa" (2 trials), "Molidustat (BAY85-3934)" (2 trials), "CP-690,550" (1 trials), "EUS-guided fistulization AXIOS" (1 trials) and "HZN-825 BID" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kitasato University Medical Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Kitasato University Medical Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Kitasato University Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kitasato University Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".